Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea
Clinical trial NCT06008678 · COMPLETED
Trial details
- NCT number
- NCT06008678
- Sponsor
- Resvent Holding USA LTD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-22
- Primary completion
- 2023-11-22
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.